|
06/09/2024
|
14:17
|
Update regarding Vice-Chairman, Salman Rahman
|
RNS
|
|
03/09/2024
|
13:45
|
Correction and Clarification of Press Commentary
|
RNS
|
|
15/08/2024
|
07:00
|
Statement regarding Vice-Chairman, Salman Rahman
|
RNS
|
|
13/08/2024
|
07:00
|
Statement on political and business situation
|
RNS
|
|
30/04/2024
|
07:00
|
Q3 Financial Results
|
RNS
|
|
04/03/2024
|
07:00
|
Appointment of Managing Director
|
RNS
|
|
30/01/2024
|
07:00
|
Half Year Results 2023-24
|
RNS
|
|
25/01/2024
|
09:53
|
Payment of Cash Dividend
|
RNS
|
|
11/01/2024
|
11:44
|
Board Change
|
RNS
|
|
28/12/2023
|
09:40
|
AGM Statement
|
RNS
|
|
06/11/2023
|
12:17
|
Notice of AGM
|
RNS
|
|
06/11/2023
|
07:00
|
Financial Results for the First Quarter
|
RNS
|
|
01/11/2023
|
07:00
|
Results for the year ended 30 June 2023
|
RNS
|
|
20/10/2023
|
07:00
|
Notification of Preliminary Results and AGM
|
RNS
|
|
11/09/2023
|
10:17
|
Clarification on Press Report
|
RNS
|
|
31/08/2023
|
15:51
|
Re-appointment of Independent Director
|
RNS
|
|
02/05/2023
|
07:00
|
Q3 Financial Results
|
RNS
|
|
11/04/2023
|
15:59
|
Holdings in Company
|
RNS
|
|
31/03/2023
|
11:03
|
Holdings in Company
|
RNS
|
|
30/01/2023
|
07:00
|
Half Year Results 2022-23
|
RNS
|
|
19/01/2023
|
07:00
|
Payment of Cash Dividend
|
RNS
|
|
23/12/2022
|
07:00
|
Annual General Meeting Statement
|
RNS
|
|
29/11/2022
|
14:06
|
Second Price Monitoring Extn
|
RNS
|
|
29/11/2022
|
14:00
|
Price Monitoring Extension
|
RNS
|
|
16/11/2022
|
07:00
|
AGM Notification
|
RNS
|
|
11/11/2022
|
07:00
|
Financial Results for the First Quarter
|
RNS
|
|
08/11/2022
|
07:00
|
Results for the 12-month period ended 30 June 2022
|
RNS
|
|
28/10/2022
|
07:00
|
Notification of Preliminary Results and AGM
|
RNS
|
|
28/04/2022
|
07:00
|
Q3 Financial Results
|
RNS
|
|
01/04/2022
|
07:00
|
Sanofi Bangladesh Ltd. renamed Synovia Pharma PLC
|
RNS
|
|
17/03/2022
|
14:30
|
MPP sub-license for Pfizer’s COVID-19 treatment
|
RNS
|
|
28/01/2022
|
07:00
|
Half Year Results 2021-22
|
RNS
|
|
21/01/2022
|
07:00
|
Payment of Cash Dividend
|
RNS
|
|
20/01/2022
|
09:00
|
License to produce molnupiravir for COVID-19
|
RNS
|
|
30/12/2021
|
10:38
|
World's first generic version of Pfizer’s Paxlovid
|
RNS
|
|
24/12/2021
|
07:00
|
Annual General Meeting Statement
|
RNS
|
|
08/12/2021
|
07:00
|
Delivery of COVID-19 vaccine doses
|
RNS
|
|
02/12/2021
|
07:00
|
Update on the supply of COVID-19 vaccine
|
RNS
|
|
24/11/2021
|
07:43
|
Statement re: media comment
|
RNS
|
|
16/11/2021
|
07:00
|
Notice of AGM
|
RNS
|
|
11/11/2021
|
10:30
|
Results for First Quarter Ended 30 September 2021
|
RNS
|
|
09/11/2021
|
07:00
|
Launch of world’s first generic molnupiravir
|
RNS
|
|
02/11/2021
|
07:00
|
Results for the year ended 30 June 2021
|
RNS
|
|
21/10/2021
|
12:36
|
Notification of Preliminary Results and AGM
|
RNS
|
|
11/10/2021
|
07:00
|
Update on the supply of COVID-19 vaccine
|
RNS
|
|
01/10/2021
|
07:00
|
Completion of Sanofi Bangladesh Acquisition
|
RNS
|
|
14/09/2021
|
10:20
|
Sanofi Bangladesh Share Purchase Agreement signed
|
RNS
|
|
03/09/2021
|
13:10
|
Acquisition Approved by Bangladesh Bank
|
RNS
|
|
25/08/2021
|
18:01
|
Statement re: media comment
|
RNS
|
|
07/07/2021
|
14:23
|
Update on the supply of COVID-19 vaccine
|
RNS
|